Bio Break: Preventive Medical Devices
In this episode of Bio Break, Nick Allan and Joris van der Heijden explore a critical but often overlooked topic in healthcare innovation: prevention. While most conversations about medical devices revolve around treatment, the duo shifts the focus to technologies that help people avoid hospitalization altogether. Preventive medical devices and diagnostic tools are quietly transforming healthcare by catching diseases earlier and reducing the need for invasive procedures.
Joris highlights three exciting examples of how medical technology is evolving to prioritize early detection and keep people healthier for longer. First up is the integration of artificial intelligence in mammography. With AI support, clinicians are now detecting 30% more breast cancers in earlier stages, according to a recent article in The Lancet. That’s a major leap in early screening, improving survival rates and minimizing the need for aggressive treatments down the line.
Next, they dive into HPV screening and the rise of self-sampling kits. Traditionally, cervical cancer screening required an in-clinic procedure. But with self-collection methods now available, people can collect samples in the privacy of their own homes, helping reduce barriers to participation and supporting earlier diagnosis.
Finally, they discuss innovations in colon cancer screening. Colonoscopies have long been a dreaded but necessary exam. Thanks to capsule endoscopy, essentially a pill with a camera, patients may soon have a more comfortable alternative for internal imaging. In addition, advanced endoscopic tools now allow clinicians to remove even large polyps without the need for invasive surgery. In many cases, patients can go home the same day, reducing recovery time and healthcare costs.
From AI diagnostics to less invasive procedures and at-home testing, this episode illustrates how medical devices are supporting proactive care, improving access, and ultimately keeping more people out of the hospital.
Related Resources
Ariana and Mark walk through what separates a clinical prototype from a proof-of-concept build, what determines how much testing and documentation you actually need, and where the regulatory line between significant risk and non-significant risk falls.
In this episode of Bio Break, Nick walks through both patent types after receiving two of his own in the mail, one of each, from the USPTO.
Scott Phillips sits down with Mickey Urdea to examine what actually distinguishes companies that reach commercial outcomes from those that do not.
Nigel Syrotuck breaks down the realistic medical device V&V cost and schedule for terminally sterilized devices, picking up after design freeze and walking through each major phase of the process.